ea0098t7 | Trials In Progress | NANETS2023
Lin Frank I.
, Del Rivero Jaydira
, Thomas Anish
, Srinivasan Ramaprasad
, Charalampos Floudas
, Carrasquillo Jorge
, Shamis Inna
, Zou Joy
, Turkbey Baris
, Mena Esther
, Lindenberg Liza
, Chen Clara
, Herscovitch Peter
, Millo Corina
, Pacak Karel
Background: Somatostatin receptors (SSTR) is overexpressed in a number of different tumors, including GI Neuroendocrine Tumors (GI-NET), Pheochromocytoma/Paraganglioma (PPGL), small cell lung cancer (SCLC), renal cell carcinoma (RCC), and certain head and neck cancers (H&N) such as olfactory neuroblastoma. It has been demonstrated that these SSTR-expressing tumors can be treated with beta-emitting radioligand therapy (RLT) that binds to SSTR such as Lu-177-DOTATATE. Howeve...